Sarepta Therapeutics, Inc. SRPT Operating Lease Liabilities
Operating Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by Sarepta Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityNoncurrent.
The official record: Sarepta Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Sarepta Therapeutics, Inc.'s operating lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Sarepta Therapeutics, Inc.'s operating lease liabilities?
- Sarepta Therapeutics, Inc. (SRPT) reported operating lease liabilities of $198.51M in Q1 2026.
- How has Sarepta Therapeutics, Inc.'s operating lease liabilities changed year-over-year?
- Sarepta Therapeutics, Inc.'s operating lease liabilities decreased by 3.4% year-over-year, from $205.46M to $198.51M.
- What is the long-term trend for Sarepta Therapeutics, Inc.'s operating lease liabilities?
- Over 5 years (2020 to 2025), Sarepta Therapeutics, Inc.'s operating lease liabilities has grown at a 19.9% compound annual growth rate (CAGR), from $80.37M to $199.38M.
- What does operating lease liabilities mean?
- Long-term portion of operating lease obligations extending beyond one year, representing committed future rent payments.